175 related articles for article (PubMed ID: 32312162)
1. Modifications on the heterocyclic base of ganciclovir, penciclovir, acyclovir - syntheses and antiviral properties.
Chuchkov K; Chayrov R; Hinkov A; Todorov D; Shishkova K; Stankova IG
Nucleosides Nucleotides Nucleic Acids; 2020; 39(7):979-990. PubMed ID: 32312162
[TBL] [Abstract][Full Text] [Related]
2. Fluorescent tricyclic analogues of acyclovir and ganciclovir. A structure-antiviral activity study.
Golankiewicz B; Ostrowski T; Goslinski T; Januszczyk P; Zeidler J; Baranowski D; de Clercq E
J Med Chem; 2001 Nov; 44(24):4284-7. PubMed ID: 11708929
[TBL] [Abstract][Full Text] [Related]
3. Fluorosubstitution and 7-alkylation as prospective modifications of biologically active 6-aryl derivatives of tricyclic acyclovir and ganciclovir analogues.
Ostrowski T; Golankiewicz B; De Clercq E; Balzarini J
Bioorg Med Chem; 2005 Mar; 13(6):2089-96. PubMed ID: 15727862
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and fluorescent properties of 6-(4-biphenylyl)-3,9-dihydro-9-oxo-5H-imidazo[1,2-a]purine analogues of acyclovir and ganciclovir.
Goslinski T; Wenska G; Golankiewicz B; Balzarini J; De Clercq E
Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):911-4. PubMed ID: 14565309
[TBL] [Abstract][Full Text] [Related]
5. Tailoring acyclovir prodrugs with enhanced antiviral activity: rational design, synthesis, human plasma stability and in vitro evaluation.
Chayrov RL; Stylos EK; Chatziathanasiadou MV; Chuchkov KN; Tencheva AI; Kostagianni AD; Milkova TS; Angelova AL; Galabov AS; Shishkov SA; Todorov DG; Tzakos AG; Stankova IG
Amino Acids; 2018 Aug; 50(8):1131-1143. PubMed ID: 29779181
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological activity of strongly fluorescent tricyclic analogues of acyclovir and ganciclovir.
Goslinski T; Golankiewicz B; De Clercq E; Balzarini J
J Med Chem; 2002 Nov; 45(23):5052-7. PubMed ID: 12408716
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and anti-HSV activity of tricyclic penciclovir and hydroxybutylguanine derivatives.
Mohammed AF; Andrei G; Hayallah AM; Abdel-Moty SG; Snoeck R; Simons C
Bioorg Med Chem; 2019 Mar; 27(6):1023-1033. PubMed ID: 30738653
[TBL] [Abstract][Full Text] [Related]
8. The novel immunosuppressive agent mycophenolate mofetil markedly potentiates the antiherpesvirus activities of acyclovir, ganciclovir, and penciclovir in vitro and in vivo.
Neyts J; Andrei G; De Clercq E
Antimicrob Agents Chemother; 1998 Feb; 42(2):216-22. PubMed ID: 9527762
[TBL] [Abstract][Full Text] [Related]
9. Resistance of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and management.
Piret J; Boivin G
Antimicrob Agents Chemother; 2011 Feb; 55(2):459-72. PubMed ID: 21078929
[TBL] [Abstract][Full Text] [Related]
10. Activity of penciclovir in antiviral assays against herpes simplex virus.
Bacon TH; Howard BA; Spender LC; Boyd MR
J Antimicrob Chemother; 1996 Feb; 37(2):303-13. PubMed ID: 8707740
[TBL] [Abstract][Full Text] [Related]
11. Antiviral activity of 9-[[(ethoxyhydroxyphosphinyl)-methoxy]methoxy] guanine against cytomegalovirus and herpes simplex virus.
Kim HT; Kim DK; Kim YW; Kim KH; Sugiyama Y; Kikuchi M
Antiviral Res; 1995 Nov; 28(3):243-51. PubMed ID: 8629816
[TBL] [Abstract][Full Text] [Related]
12. Characterization of herpes simplex viruses selected in culture for resistance to penciclovir or acyclovir.
Sarisky RT; Quail MR; Clark PE; Nguyen TT; Halsey WS; Wittrock RJ; O'Leary Bartus J; Van Horn MM; Sathe GM; Van Horn S; Kelly MD; Bacon TH; Leary JJ
J Virol; 2001 Feb; 75(4):1761-9. PubMed ID: 11160674
[TBL] [Abstract][Full Text] [Related]
13. C-5 hydroxyethyl and hydroxypropyl acyclonucleosides as substrates for thymidine kinase of herpes simplex virus type 1 (HSV-1 TK): syntheses and biological evaluation.
Meščić A; Krištafor S; Novaković I; Osmanović A; Müller U; Završnik D; Ametamey SM; Scapozza L; Raić-Malić S
Molecules; 2013 May; 18(5):5104-24. PubMed ID: 23644977
[TBL] [Abstract][Full Text] [Related]
14. Structure-Activity Relationships of Acyclic Selenopurine Nucleosides as Antiviral Agents.
Sahu PK; Umme T; Yu J; Kim G; Qu S; Naik SD; Jeong LS
Molecules; 2017 Jul; 22(7):. PubMed ID: 28704950
[TBL] [Abstract][Full Text] [Related]
15. Successful kinase bypass with new acyclovir phosphoramidate prodrugs.
McGuigan C; Derudas M; Bugert JJ; Andrei G; Snoeck R; Balzarini J
Bioorg Med Chem Lett; 2008 Aug; 18(15):4364-7. PubMed ID: 18614365
[TBL] [Abstract][Full Text] [Related]
16. [Antiherpetic activity of 5-alkynyl derivatives of 2'-deoxyuridine].
Andronova VL; Pchelintseva AA; Ustinov AV; Petrunina AL; Korshun VA; Skorobogatyĭ MV; Galegov GA
Vopr Virusol; 2006; 51(1):34-8. PubMed ID: 16515041
[TBL] [Abstract][Full Text] [Related]
17. Comparison of a DNA probe assay with the plaque reduction assay for measuring the sensitivity of herpes simplex virus and varicella-zoster virus to penciclovir and acyclovir.
Standring-Cox R; Bacon TH; Howard BA
J Virol Methods; 1996 Jan; 56(1):3-11. PubMed ID: 8690764
[TBL] [Abstract][Full Text] [Related]
18. [Sensitivities to other antiviral drugs and thymidine kinase activity of aciclovir-resistant herpes simplex virus type 1].
Nitta K; Shiota H; Naito T; Mimura Y
Nippon Ganka Gakkai Zasshi; 1994 Jun; 98(6):513-9. PubMed ID: 8030564
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo activity of 1-O-hexadecylpropanediol-3-phospho-ganciclovir and 1-O-hexadecylpropanediol-3-phospho-penciclovir in cytomegalovirus and herpes simplex virus infections.
Hostetler KY; Rybak RJ; Beadle JR; Gardner MF; Aldern KA; Wright KN; Kern ER
Antivir Chem Chemother; 2001 Jan; 12(1):61-70. PubMed ID: 11437323
[TBL] [Abstract][Full Text] [Related]
20. Three-dimensional analysis of combination effect of ellagitannins and acyclovir on herpes simplex virus types 1 and 2.
Vilhelmova N; Jacquet R; Quideau S; Stoyanova A; Galabov AS
Antiviral Res; 2011 Feb; 89(2):174-81. PubMed ID: 21134403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
